Technology Portfolio

Subdural Hematoma Port

Clinical experts at Wake Forest have designed an improved Subdural Hematoma Port that combines the proven clinical utility of existing hematoma ports with an added functionality to mechanically break-up clots that obstruct the port.

Technology Overview

Reference #: WFU 09-13

Subdural hematomas can develop clots that can obstruct a drainage port such as the Medtronic SEPS product ($1,000 per kit). When an obstruction forms, it must be removed before drainage can continue. Having to remove the drainage port is wasteful, time-consuming and represents an additional infection risk for the patient.

Wake Forest’s Subdural Hematoma Port incorporates a stylet that can mechanically disrupt an obstructed drainage port and restore flow.

An initial prototype has been created that is suitable for preliminary testing.

Charles Branch, Jr., MD
Neurosurgery

Start a Conversation

John Druga
John Druga, MS, MBA
Licensing Director, Technology Commercialization

+1.336.716.4421

jdruga@wakehealth.edu